No Data
No Data
Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT
Express News | Reported Earlier, Metagenomi Shares Data On SMART Gene Editing Platform At AIChE Conference, Emphasizing AAV Packaging
We Think Metagenomi (NASDAQ:MGX) Needs To Drive Business Growth Carefully
Microsoft, BlackRock Plan $30 Billion AI Infrastructure Fund -- Barrons.com
H.C. Wainwright Maintains Metagenomi Technologies, LLC(MGX.US) With Buy Rating, Maintains Target Price $7
Metagenomi Price Target Maintained With a $15.00/Share by Chardan Capital
No Data
No Data
104476495 : h
Yolion : should I sell all my shares?